Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Mini
8
186
2027
43%
chance

Resolves YES if the FDA grants full approval for the commercial sale of any mRNA vaccine against non-small-cell lung carcinoma in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.

Get Ṁ600 play money
Sort by:

I think this is second most likely to get approval - very high market demand, high mutational load, already approved for checkpoint inhibitor therapy.

More related questions